ABBOTT LABORATORIES (ABT) Stock Balance Sheet
USA - NYSE:ABT - US0028241000 - Common Stock
128.82 USD
+1.82 (+1.43%)
129.14 USD
+0.32 (+0.25%)
| MRQ (2025-9-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | null | null | null | null | null | |||
| Cash Equivalents | 7.51B | 7.62B | 6.90B | 9.88B | 9.80B | |||
| Cash Due From Banks | null | null | null | null | null | |||
| Investments | null | null | null | null | null | |||
| Net Loans | null | null | null | null | null | |||
| Insurance Receivables | null | null | null | null | null | |||
| Marketable Securities | 222.00M | 351.00M | 383.00M | 288.00M | 450.00M | |||
| Receivables | 8.14B | 6.92B | 6.57B | 6.22B | 6.49B | |||
| Inventories | 6.71B | 6.19B | 6.57B | 6.17B | 5.16B | |||
| Other Current Assets | 2.26B | 2.57B | 2.26B | 2.66B | 2.35B | |||
| Total Current Assets | 24.84B | 23.66B | 22.67B | 25.22B | 24.24B | |||
| Non-Current Assets | ||||||||
| PPE Net | 11.50B | 11.73B | 11.28B | 10.28B | 10.11B | |||
| Investments And Advances | 951.00M | 886.00M | 799.00M | 766.00M | 816.00M | |||
| Goodwill | 23.97B | 23.11B | 23.68B | 22.80B | 23.23B | |||
| Intangibles | 5.60B | 6.65B | 8.81B | 10.45B | 12.74B | |||
| Other Non-Current Assets | 17.32B | 15.38B | 5.97B | 4.92B | 4.06B | |||
| Total Non-Current Assets | 59.34B | 57.76B | 50.54B | 49.21B | 50.96B | |||
| TOTAL ASSETS | 84.18B | 81.41B | 73.21B | 74.44B | 75.20B | |||
| LIABILITIES | ||||||||
| Total Deposits | null | null | null | null | null | |||
| Current Liabilities | ||||||||
| Short Term Borrowings | null | null | null | null | null | |||
| Short Term Debt | 0 | 0 | 0 | 0 | 0 | |||
| Current Portion Of LT Debt. | 1.34B | 1.50B | 1.08B | 2.25B | 754.00M | |||
| Accrued Expenses | 7.62B | 6.84B | 7.02B | 7.40B | 6.81B | |||
| Accounts Payable | 4.12B | 4.20B | 4.29B | 4.61B | 4.41B | |||
| Other Current Liabilities | 1.50B | 1.62B | 1.45B | 1.23B | 1.14B | |||
| Total Current Liabilities | 14.58B | 14.16B | 13.84B | 15.49B | 13.11B | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 11.60B | 12.63B | 13.60B | 14.52B | 17.30B | |||
| Deferred Taxes/Income | null | 512.00M | 568.00M | 991.00M | 1.39B | |||
| Other Non-Current Liabilities | 6.74B | 6.22B | 6.38B | 6.53B | 7.38B | |||
| Total Non-Current Liabilities | 18.64B | 19.59B | 20.77B | 22.26B | 26.29B | |||
| TOTAL LIABILITIES | 33.23B | 33.75B | 34.61B | 37.75B | 39.39B | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | 49.10B | 47.26B | 37.55B | 35.26B | 31.53B | |||
| Additional Paid In Capital | null | null | null | null | null | |||
| Minority Interest | 310.00M | 237.00M | 224.00M | 219.00M | 222.00M | |||
| Common Shares | 25.41B | 25.15B | 24.87B | 24.71B | 24.47B | |||
| Treasury Stock | -16.88B | -16.84B | -15.98B | -15.23B | -11.82B | |||
| Other Shareholders' Equity | -6.68B | -7.91B | -7.84B | -8.05B | -8.37B | |||
| Shares Outstanding | 1.74B | 1.73B | 1.73B | 1.74B | 1.76B | |||
| Tangible Book Value per Share | 12.2982 | 10.3419 | 3.5229 | 1.9755 | -0.0952 | |||
| Total Shareholders' Equity | 50.95B | 47.66B | 38.60B | 36.69B | 35.80B | |||
| TOTAL LIABILITIES AND EQUITY | 84.18B | 81.41B | 73.21B | 74.44B | 75.20B | |||
| Statistics | ||||||||
| Debt/Equity | 0.23 | 0.26 | 0.35 | 0.40 | 0.48 | |||
| Current Ratio | 1.70 | 1.67 | 1.64 | 1.63 | 1.85 | |||
| Return On Assets (ROA) | 16.60% | 16.46% | 7.82% | 9.31% | 9.40% | |||
| Return On Equity (ROE) | 27.43% | 28.12% | 14.83% | 18.90% | 19.75% | |||
| Return On Invested Capital (ROIC) | 9.90% | 8.93% | 9.72% | 12.68% | 11.88% | |||
| Return On Invested Capital Ex Cash (ROICexc) | 11.13% | 10.13% | 11.08% | 15.33% | 14.23% | |||
| Return On Invested Capital Ex Cash + Goodwill (ROICexgc) | 21.33% | 20.33% | 29.45% | 48.16% | 46.47% | |||
All data in USD , ROIC based on taxRate of 0.14